Stifel maintains Healwell AI buy rating and C$2.25 target
Baystreet reports Stifel maintains a Buy rating on Healwell AI Inc. and keeps its C$2.25/share price target.
Site Search
Search market news
Find public news by keyword, exact ticker, category and date.
Matching instruments
Open a ticker page for its news coverage. The news search below stays a text search.